(Q33769745)

29 July 2017

1 reference

title

Considerations in the selection of a platelet component: apheresis versus whole blood-derived (English)

1 reference

29 July 2017

Chambers LA

1

1 reference

29 July 2017

Herman JH

series ordinal

2

1 reference

29 July 2017

publication date

1 October 1999

1 reference

Transfusion Medicine Reviews

29 July 2017

published in

1 reference

29 July 2017

volume

13

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

311-322

1 reference

Clinical perspectives of platelet transfusions: defining the optimal dose

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Collection and transfusion of blood and blood components in the United States, 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Single donor platelets: can we afford to use them? Can we afford not to use them?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Evaluation of platelet concentrates stored for 5 days with reduced plasma volume

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

White cell subsets in apheresis and filtered platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Low cytokine contamination in buffy coat-derived platelet concentrates without filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Collection of platelets with a new cell separator and their storage in a citrate-plasticized container

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

In vitro and in vivo effects of prestorage filtration of apheresis platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Effect of storage time on clinical efficacy of single-donor platelet units

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Paired in vivo and in vitro comparison of apheresis and "recovered" platelet concentrates stored for 5 days

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Frequency and causes of refractoriness in multiply transfused patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Reports of 355 transfusion-associated deaths: 1976 through 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Case report: fatal Staphylococcus aureus sepsis from single-donor platelet transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Fatal Salmonella septicemia after platelet transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Hypotensive reactions: a previously uncharacterized complication of platelet transfusion?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Anaphylatoxins in fresh-frozen plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Complement activation during storage of single-donor platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Analysis of the priming activity of lipids generated during routine storage of platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

The relationship between the duration of platelet storage and the development of transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Febrile reactions after platelet transfusion: the effect of single versus multiple donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

The role of the plasma from platelet concentrates in transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

The febrile platelet transfusion reaction: a cytokine shower

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Cytokine generation in stored platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Leukocyte depletion and storage of single-donor platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Comparison of the level of cytokine mRNA in buffy coat-derived platelet concentrates prepared with or without white cell reduction by filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Use of irradiated blood components: practice parameter

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Transfusion therapy and HLA antibody response in patients undergoing open heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

1 reference

7 January 2021

Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Selection of platelets for refractory patients by HLA matching and prospective crossmatching

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Platelet crossmatches of single-donor platelet concentrates using a latex agglutination assay

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

A prospective study of symptomatic bacteremia following platelet transfusion and of its management

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

Strategies for the avoidance of bacterial contamination of blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2899%2980060-1

7 January 2021

10.1016/S0887-7963(99)80060-1

Identifiers

DOI

1 reference

29 July 2017

1 reference